During the past decade, Wojewodzkie Centrum Onkologii conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 9 clinical trials were completed, i.e. on average, 56.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 6 clinical trials were completed. i.e. 85.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wojewodzkie Centrum Onkologii" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Pfizer" with 4 trials sponsored, "BeiGene" with 3 trials sponsored, "Alaunos Therapeutics" with 2 trials sponsored and "Eisai Inc." with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wojewodzkie Centrum Onkologii" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Eisai Europe Ltd. (United Kingdom)" with 1 trials as a collaborator and "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Wojewodzkie Centrum Onkologii" are "Metastatic Breast Cancer" (5 trials), "Chronic Lymphocytic Leukemia" (3 trials), "Breast Cancer" (2 trials), "Ovarian Cancer" (2 trials) and "Small Lymphocytic Lymphoma" (2 trials). Many other conditions were trialed in "Wojewodzkie Centrum Onkologii" in a lesser frequency.

Most popular intervention types in "Wojewodzkie Centrum Onkologii" are "Drug" (26 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (4 trials), "Capecitabine" (3 trials), "Bevacizumab" (2 trials), "Carboplatin" (2 trials) and "Cetuximab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Wojewodzkie Centrum Onkologii" are 19 trials for "All" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "Wojewodzkie Centrum Onkologii". undefined are not yet recruiting, 6 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Wojewodzkie Centrum Onkologii, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Wojewodzkie Centrum Onkologii, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".